Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

3.4

Asthma In Pregnancy

Obstetrics & Gynaecology Protocols, Version 3.0, 2017. Chapter 3, Medical Conditions in Pregnancy.

Clinical description

Asthma occurs when there is reversible bronchoconstriction and affects 4-12% of pregnancies.

It is associated with increased risk of mortality, preeclampsia, preterm delivery (PTD) and low birth weight.

Asthma is unpredictable in pregnancy: 1/3 of women report improvement, 1/3 remain the same, and 1/3 worsen.

Classificatio Persistent Intermittent n Mild Moderate Severe Symptoms ≤ 2 days/wk > 2 days/wk Daily Throughout the day but not daily Night time ≤ 2 3-4 >1 time/week but Often 7 times/week awakenings times/month times/month not nightly Short acting ≤ 2 days/wk > 2 days/wk Daily Several times/day beta 2 agonist but not daily use for and not > 1 symptom time on any control day Interference None Minor Some limitation Extremely limited with normal limitation activity Lung • Normal • FEV1 > • FEV1 60-79% • FEV1 < 60% function FEV1 80% predicted predicted between predicted • FEV1/FVC • FEV1/FVC reduced exacerbation • FEV1/FV reduced by ≤ by >5% s C normal 5% 80% predicted normal

Signs and symptoms

History/ExamTrigger (often viral), chest tightness, shortness of breath; cough, wheezing, decreased pulse ox InvestigationsPeak flow meter or spirometry, pulse oximetry

Treatment

Avoid triggers and use inhaled corticosteroids to decrease underlying inflammation

  • Antenatal clinic visit monthly if on regular meds
  • Peak flow meter BD (first thing in the morning and 12 hrs later) if available
  • Avoid allergens and tobacco
  • Avoid GERD in 3rd trimester by using PPI or H2 blocker
  • For mild - moderate persistent asthma: salbutamol inhaler 1-2 puffs TDS or corticosteroid inhaler (i.e.

beclomethasone)

  • For acute and/or severe exacerbations:
  • Admit to HDU

Clinical description

  • O2 therapy to keep SaO2 >95%
  • inhaled bronchodilator (salbutamol, ipromium bromide and normal saline)through a nebulizer or

spacer every 10-20 min until improvement seen

  • IV fluids
  • IV Aminophylline 250 mg over 10 min or MGSo4 2g stat
  • Sit up
  • 4-hourly fetal monitoring
  • Systemic steroids (i.e. hydrocortisone or prednisone IV) for up to 5-7 days
  • Continuously assess response to treatment, complete response is resolution of symptoms and

 Incomplete response is continuation of symptoms PEFR<80% personal best  Urgent intervention required when PEFR <50% personal best

  • Indication for intubation and ventilation: inability to maintain respiratory drive, worsening hypercapnia,

respiratory acidosis, confusion and inability to maintain SpO2> 95% despite high flow oxygen

  • Intrapartum management: continue regular inhaler prn
  • Use of IV hydrocortisone if patient has been on oral steroids >7.5mg/day for >2 weeks
  • Misoprostol if indication for labour induction
  • Oxytocin if PPH
  • Avoid use of PGF and ergometrine

2

Tables and figures

Figure from the guideline
Table, page 69 of the printed guideline. Open the image to zoom.

Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.